PD Dr. Laura Hinze
Laura Hinze is a Principal Investigator in SP5 and a member of the Selection Committee.
Her research focus lies on the mechanisms of amino acid metabolism in cancer cells.
Dr. Hinze has been a member of the Hannover Biomedical Research School for training MD and Phd students since 2020, of the Physician Scientist Program "TITUS" since 2021, of the Selection Committee of the Studienstiftung des deutschen Volkes since 2022, and of the Mildred School Committee of the DKH since 2022.
| Year | Position |
|---|---|
| 2023 | Habilitation, Experimental Pediatric Hematology and Oncology (PD Dr. med.), MHH |
| Since 2021 | Medical resident, Department of Pediatric Hematology and Oncology, MHH |
| Since 2021 | Max-Eder Junior Research Group Leader, Department of Pediatric Hematology and Oncology, MHH |
| 2021 | Doctor of Medicine (Dr. med.), MHH (Supervisor: Prof. Dr. Martin Stanulla) |
| 2019 – 2021 | Establishment of Junior Research Group, Department of Pediatric Hematology and Oncology, MHH |
| 2017 – 2019 | Postdoctoral Fellow, Boston Children’s Hospital/Dana Farber Cancer Institute, Supervisor: Prof. Dr. Alejandro Gutierrez |
| 2015 – 2016 | Doctoral thesis, Supervisor: Prof. Dr. Martin Stanulla |
| 2013 – 2020 | Studies of Human Medicine, MHH |